CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 137 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2014. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $47,255,000 | -8.1% | 1,873,718 | +1.5% | 0.26% | -7.6% |
| Q1 2015 | $51,427,000 | +33.5% | 1,845,248 | -12.6% | 0.28% | +29.9% |
| Q4 2014 | $38,518,000 | +46.0% | 2,110,548 | +3.7% | 0.21% | +42.7% |
| Q3 2014 | $26,387,000 | -20.4% | 2,036,033 | +0.2% | 0.15% | -16.2% |
| Q2 2014 | $33,156,000 | -13.3% | 2,031,633 | -6.2% | 0.18% | -10.9% |
| Q1 2014 | $38,254,000 | -28.3% | 2,164,918 | -1.7% | 0.20% | -25.3% |
| Q4 2013 | $53,323,000 | -19.1% | 2,202,508 | +18.4% | 0.27% | -27.3% |
| Q3 2013 | $65,933,000 | +256.4% | 1,860,933 | +57.0% | 0.37% | +224.6% |
| Q2 2013 | $18,500,000 | – | 1,185,128 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |